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Abstract
Aggregatibacter actinomycetemcomitans is a Gram-negative opportunistic pathogen and the proposed causative agent of
localized aggressive periodontitis. A. actinomycetemcomitans is found exclusively in the mammalian oral cavity in the space
between the gums and the teeth known as the gingival crevice. Many bacterial species reside in this environment where
competition for carbon is high. A. actinomycetemcomitans utilizes a unique carbon resource partitioning system whereby
the presence of L-lactate inhibits uptake of glucose, thus allowing preferential catabolism of L-lactate. Although the
mechanism for this process is not fully elucidated, we previously demonstrated that high levels of intracellular pyruvate are
critical for L-lactate preference. As the first step in L-lactate catabolism is conversion of L-lactate to pyruvate by lactate
dehydrogenase, we proposed a model in which the A. actinomycetemcomitans L-lactate dehydrogenase, unlike homologous
enzymes, is not feedback inhibited by pyruvate. This lack of feedback inhibition allows intracellular pyruvate to rise to levels
sufficient to inhibit glucose uptake in other bacteria. In the present study, the A. actinomycetemcomitans L-lactate
dehydrogenase was purified and shown to convert L-lactate, but not D-lactate, to pyruvate with a Km of approximately
150 mM. Inhibition studies reveal that pyruvate is a poor inhibitor of L-lactate dehydrogenase activity, providing mechanistic
insight into L-lactate preference in A. actinomycetemcomitans.
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Introduction
Aggregatibacter actinomycetemcomitans is a Gram-negative, nonmo-
tile, opportunistic pathogen that resides exclusively in the
mammalian oral cavity [1] and has been proposed to be the
primary cause of the tooth and gum disease known as localized
aggressive periodontitis [2,3]. Within the oral cavity, A. actinomy-
cetemcomitans resides in the gingival crevice, defined as the
microaerophilic region bounded by the tooth surface and the
epithelium lining the gingiva. The gingival crevice is bathed in
gingival crevicular fluid (GCF) which provides nutrients for a
robust and complex community of microorganisms. As a serum
exudate, GCF likely contains several potential carbon sources to
support this microbial community, including glucose, lactate, and
fructose [4,5]. Competition for resources is high in this
environment and the rate of consumption of carbohydrates is
extremely rapid [6,7,8], likely due to the large number of oral
streptococci.
We recently showed that although A. actinomycetemcomitans
divides faster and achieves higher cell yields when catabolizing
glucose, L-lactate is preferentially utilized [9]. Interestingly, L-
lactate addition to a chemically defined medium inhibited A.
actinomycetemcomitans uptake of glucose, a process referred to as PTS
substrate exclusion [9]. Glucose transport in A. actinomycetemcomitans
utilizes the phosphotransferase system (PTS). The PTS involves
transport of glucose across the cytoplasmic membrane through a
sugar-specific channel and concomitant phosphorylation upon
entry into the cell to produce glucose-6-phosphate. The phospho-
ryl group originates from the phosphodonor, phosphoenolpyr-
uvate (PEP), and is subsequently passed through a series of PTS
proteins and ultimately to glucose (Fig. 1). The first step in PTS
transport involves protein EI, which undergoes autophosphoryla-
tion in the presence of PEP to yield pyruvate and EI,P. The
phosphoryl group is then transferred to HPr, followed by a sugar-
specific EII protein, which then phosphorylates the incoming
sugar [10]. The intracellular ratio of PEP:pyruvate plays a crucial
role in PTS transport. Indeed, as the PEP:pyruvate ratio declines,
the model Gram-negative organism Escherichia coli displays reduced
uptake of several PTS carbohydrates [11]. Interestingly, L-lactate-
grown A. actinomycetemcomitans produces extremely elevated intra-
cellular levels of pyruvate [9], supporting a model in which
elevated intracellular levels of pyruvate during catabolism of L-
lactate inhibit glucose transport via reduction of the PEP:pyruvate
ratio (Fig. 1).
One of the intriguing questions regarding this model is how the
extremely high levels of intracellular pyruvate (approximately
50 mM) are produced during growth with L-lactate. In this study,
we hypothesized that potential clues might be gained by
examining the A. actinomycetemcomitans enzyme required for the
first step in L-lactate catabolism, namely L-lactate oxidation to
pyruvate. We show that the gene AA02749 (lctD) encodes for an
NAD-independent L-lactate dehydrogenase that is critical for
growth of A. actinomycetemcomitans with L-lactate. Interestingly,
inhibitor studies reveal that unlike homologous enzymes, A.
actinomycetemcomitans LctD maintains significant enzymatic activity,
even at extremely high pyruvate levels (50 mM).
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AA02769 Is Required for Growth with L-Lactate
A. actinomycetemcomitans resides within the gingival crevice where
it likely encounters levels of L-lactate ranging from 1–5 mM [5],
and previous work in our lab demonstrated that this bacterium
preferentially catabolizes L-lactate [9]. The first step in L-lactate
catabolism is the conversion of L-lactate to pyruvate via the
enzyme L-lactate dehydrogenase. Examination of the A. actinomy-
cetemcomitans HK1651 genome sequence revealed two genes with
high homology to lactate dehydrogenases: AA02769 (gene
designations from www.oralgen.lanl.gov) putatively encodes a
protein with 75% identity (E value,10
2169 using BLASTp) to the
catabolic L-lactate dehydrogenase (LctD) from E. coli K12 and
AA02749 putatively encodes a protein with 73% identity (E
value,10
2141 using BLASTp) to the fermentative D-lactate
dehydrogenase (LdhA) from E. coli K12. Based on the fact that
LdhA homologs are primarily utilized for lactate biosynthesis in
fermentative reactions [12,13], and that A. actinomycetemcomitans
does not grow with D-lactate as the sole carbon source (data not
shown), we hypothesized that AA02769 likely encodes the enzyme
required for growth on L-lactate. To test this hypothesis, the
ability of an A. actinomycetemcomitans strain containing an insertion
in AA02769 to grow with L-lactate as the sole catabolizable
carbon source was assessed. Indeed, inactivation of AA02769
eliminated the ability of A. actinomycetemcomitans to grow with L-
lactate, but not glucose (Fig. 2). Based on these results, along with
those described below, we will refer to AA02769 as lctD.
Over-Expression and Purification of LctD
A. actinomycetemcomitans lctD putatively encodes a 42 kDa
cytoplasmic protein that is a proposed member of a family of
NAD-independent L-lactate dehydrogenases that convert L-
lactate to pyruvate in a unidirectional manner [14]. Due to its
high homology to the catabolic L-lactate dehydrogenase from E.
coli and the observation that inactivation of lctD eliminated L-
lactate-dependent growth of A. actinomycetemcomitans (Fig. 2), we
hypothesized that A. actinomycetemcomitans LctD catalyzes the
oxidation of L-lactate to pyruvate. To test this hypothesis, A.
actinomycetemcomitans lctD was cloned into the pET21a(+) expression
vector (pSB103) to create C-terminally his6-tagged LctD. Affinity
purification using a nickel column resulted in nearly pure LctD-
his6 as demonstrated by a prominent band at approximately 42-
kDa on a Coomassie stained gel (Fig. 3A) and a single band in a
Western blot using an anti-his6 antibody (Fig. 3B). As a control, a
purification procedure was performed using cells containing
pET21a(+), which resulted in no proteins readily apparent by
SDS-PAGE analysis after purification and no L-lactate dehydro-
genase enzyme activity (data not shown).
In addition to C-terminally his6-tagged LctD, N-terminally his6-
tagged LctD was also constructed and purified. While both
purified enzymes displayed enzymatic activity, they were extreme-
ly unstable and exhibited significant loss of enzymatic activity in a
variety of buffers after overnight storage at 4, 220, or 280uC;
therefore all assays were carried out using freshly purified protein.
Of note, protein activity from independent purifications was
consistent and reproducible. LctD-his6 was used for enzymatic
characterization as its yields were somewhat higher than those of
his6-LctD.
Figure 1. PTS substrate exclusion model. Lactate enters the cell
through the lactate permease (LctP) and is converted to pyruvate by L-
lactate dehydrogenase (LctD). Intracellular levels of pyruvate increase
and prevent autophosphorylation of protein EI, thus inhibiting PTS-
mediated carbohydrate transport. PEP is phosphoenolpyruvate.
doi:10.1371/journal.pone.0007864.g001
Figure 2. LctD is required for growth using L-lactate. Growth
curves of wild-type A. actinomycetemcomitans and the A. actinomyce-
temcomitans lctD insertion mutant in chemically defined medium (CDM)
containing 20 mM glucose or 20 mM L-lactate as the sole source of
energy. Glucose-grown A. actinomycetemcomitans (¤), L-lactate-grown
A. actinomycetemcomitans (m), glucose-grown A. actinomycetemcomi-
tans lctD
2 (&), L-lactate-grown A. actinomycetemcomitans lctD
2 (N).
doi:10.1371/journal.pone.0007864.g002
Figure 3. Purification of LctD-his6. (A) SDS-PAGE analysis of LctD-
his6. LctD-his6 was purified using a HisTrap nickel column and examined
by SDS-PAGE and Coomassie staining. Lane designations above the gel
are: (La), molecular weight ladder; (Ly), cell lysate; (W1), buffer A flow-
through; (W2), buffer B with 0.15 M imidazole flow-through; (W3),
buffer B with 0.5 M imidazole flow-through; (LctD), phosphate buffer-
exchanged LctD-his6. Numbers to the left of the SDS-PAGE gel
represent size standards in kilodaltons. Phosphate buffer-exchanged
LctD-his6 was used for enzymatic activity studies. (B) Western blot
analysis of purified LctD-his6. Purified LctD-his6 was separated on a 10%
SDS-PAGE gel, transferred to nitrocellulose membrane, and detected
using an anti-his6 antibody and chemiluminescence. Image represents
an overlay of a white light image and a chemiluminescent image.
doi:10.1371/journal.pone.0007864.g003
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Once purified protein was obtained, the enzymatic activity of
LctD-his6 was assessed. The final electron acceptor of many NAD-
independent enzymes is unknown, as these enzymes are likely
coupledtoelectrontransport[14].Therefore,LctD-his6 activitywas
determined in the presence of the electron carriers 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)
and phenazine methosulfate (PMS) as previously described
[15,16,17]. LctD-his6 catalyzed the oxidation of L-lactate to
pyruvate (Fig. 4B); however, no activity was observed with the D-
lactate isomer (Fig. 4C). Additionally, LctD-his6 was unable to
catalyze the reverse reaction (pyruvate to lactate) even in the
presence of the reduced substrate NADH (data not shown). These
data indicate that, as expected, LctD-his6 is an NAD-independent
L-lactate dehydrogenase that catalyzes the oxidation of L-lactate to
pyruvate in a unidirectional manner.
After determining that the product of LctD-his6 L-lactate
oxidation was pyruvate, kinetic analysis was performed. For kinetic
analysis, reduction of MTT (measured as the change in
absorbance at 570 nm) was utilized to monitor LctD-his6 activity
as previously described [15,16,17]. Activity assays were carried out
in the presence of saturating substrate concentrations, and it was
determined that with 8 nM enzyme, 4 mM lactate, and 60 mg/ml
MTT, 240 mg/ml PMS achieved linear results for a 10 minute
duration (Fig. 5A). To acquire a Km value, activity assays were
performed in the presence of increasing lactate concentrations,
and a Km value of approximately 150 mM was calculated using
SigmaPlot 10.0.1 software (Fig. 5B).
Pyruvate Is a Poor Inhibitor of LctD
Our model for PTS substrate exclusion involves the production
of high levels of intracellular pyruvate during growth with L-
lactate (Fig. 1). Based on this model, we hypothesized that A.
actinomycetemcomitans LctD-his6 would not be sensitive to feedback
inhibition by product (pyruvate) accumulation; thus allowing
intracellular accumulation of pyruvate to the high levels (50 mM)
previously observed [9]. Interestingly, LctD homologs from other
bacteria are often inhibited by relatively low levels (5 mM) of
pyruvate [18]. To assess the impact of pyruvate on A.
actinomycetemcomitans LctD-his6 activity, inhibition assays were
Figure 4. LctD-his6 catalyzes oxidation of L-lactate, but not D-
lactate, to pyruvate. HPLC chromatogram of LctD-his6 in vitro
enzyme reactions with (A) L-lactate as the substrate at time 0, (B) L-
lactate as the substrate after 15 min, and (C) D-lactate as the substrate
after 15 min. Pyruvate and D- and L-lactate were detected using a
refractive index detector, and data are displayed as peak height
(microvolts). Using commercially available standards, it was determined
that pyruvate is detected at approximately 11.6 to 12.1 min and lactate
(D and L) is detected at approximately 14.6 to 15.2 min. Representative
data are shown for experiments that were performed in duplicate or
triplicate.
doi:10.1371/journal.pone.0007864.g004
Figure 5. Kinetic analysis of LctD-his6. LctD-his6 was incubated
with L-lactate and enzymatic activity assessed by monitoring reduction
of MTT as described [15,16,17]. (A) Enzymatic activity was assessed over
time for multiple LctD-his6 concentrations (4, 5, 8, 10, and 12 nM) in the
presence of saturating substrate concentrations. For Km calculations,
8 nM LctD-his6 was used. Representative data are shown. (B) The LctD-
his6 Km for lactate was calculated as 152623 mM (average6standard
deviation) by averaging values from quadruplicate experiments.
Representative data are shown.
doi:10.1371/journal.pone.0007864.g005
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as well as the common lactate dehydrogenase inhibitor oxalate
[19,20]. Pyruvate displayed poor inhibition of LctD-his6 activity,
with approximately 90% activity remaining in the presence of
5 mM pyruvate and 50% activity remaining in the presence of
50 mM pyruvate (Fig. 6). As expected, oxalate was a potent
inhibitor of LctD activity, with 50% inhibition observed at
approximately 2 mM oxalate (Fig. 6).
Discussion
A. actinomycetemcomitans is found exclusively in the mammalian
oral cavity, a diverse environment where microbes likely compete
for limited carbon sources including glucose, L-lactate, and
fructose [4,5]. While a large number of oral bacteria preferentially
catabolize carbohydrates, previous results from our laboratory
revealed that A. actinomycetemcomitans has evolved a preference for
L-lactate despite its apparent inferiority as a carbon and energy
source [9]. This unique mechanism for preferential L-lactate
consumption, referred to as PTS substrate exclusion [9], may have
benefits for A. actinomycetemcomitans as it may mitigate L-lactate-
mediated acidification of the gingival crevice as well as reduce
production of the antimicrobial H2O2 by oral streptococci [21].
Thus preferential consumption of L-lactate by A. actinomycetemco-
mitans may be a unique survival strategy allowing A. actinomyce-
temcomitans to compete with other members of the oral microbiota
in vivo.
We recently proposed a model for PTS substrate exclusion in
which intracellular levels of pyruvate inhibit glucose uptake in L-
lactate-grown A. actinomycetemcomitans (Fig. 1). As this model is
predicated on the accumulation of pyruvate to intracellular levels
approximately 10 times higher than normally found in glucose
growing bacteria [9], we hypothesized that the A. actinomycetemco-
mitans L-lactate dehydrogenase (LctD) is not feedback inhibited by
high levels of pyruvate. To test this hypothesis, A. actinomycetemco-
mitans LctD was purified as a C-terminal his6 fusion protein and
determined to be an NAD-independent L-lactate dehydrogenase
that catalyzes irreversible oxidation of L-lactate to pyruvate
(Fig. 4B). LctD-his6 displayed a Km for L-lactate of approximately
150 mM, a value within the range of other characterized NAD-
independent lactate dehydrogenases [14,18,22], including the
highly homologous E. coli LctD enzyme (75% identity) that has a
Km value of 21–70 mM [22].
A. actinomycetemcomitans LctD-his6 was highly resistant to
feedback inhibition by pyruvate, displaying 50% activity at
50 mM pyruvate (Fig. 6). This property is unique in that
homologous enzymes in other bacteria display feedback inhibition
by substantially lower levels of pyruvate. Indeed, the NAD-
independent lactate dehydrogenase of Propionibacterium pentosaceum
is inhibited by levels of pyruvate (1–5 mM) commonly observed
intracellularly [18]. Our results reveal that LctD allows A.
actinomycetemcomitans to specifically convert L-lactate to pyruvate
in a unidirectional manner. Since this enzyme displays reduced
inhibition by pyruvate, intracellular levels of pyruvate rise to levels
known to inhibit PTS transport in other bacteria [11,23], resulting
in PTS substrate exclusion. While the PTS enzyme(s) affected by
high levels of pyruvate is not known, we hypothesize that
inhibition occurs at the first step of PTS transport, phosphoryla-
tion of protein EI by PEP (Fig. 1), and studies in our laboratory are
currently addressing this hypothesis.
Materials and Methods
Bacterial Strains and Culture Conditions
A. actinomycetemcomitans strain VT1169 [24] and the A.
actinomycetemcomitans ldhA mutant (referred to as the lctD mutant
in this manuscript) [9] was grown in chemically defined
Socransky’s medium [25] lacking DL-mevalonic acid and hemin
(referred to as Chemically Defined Medium, CDM) or tryptic soy
broth with 0.5% yeast extract (TSBYE). Cultures were grown with
shaking at 165 RPM at 37uC with a 10% CO2 atmosphere. For
growth analysis, overnight TSBYE-grown cultures were washed
three times with warm (37uC) CDM containing no catabolizable
carbon source and diluted to an optical density at 600 nm
(OD600 nm) of 0.015 in CDM supplemented with 20 mM L-lactate
or glucose. E. coli DH5a and BL21(DE3) were grown in Luria
broth (LB), shaking at 250 RPM at 37uC, with 75 mg/ml
ampicillin for plasmid maintenance or 100 mg/ml for selection.
Construction of N- and C-Terminally Tagged LctD
The lctD gene from A. actinomycetemcomitans strain 1169 was
amplified by PCR using primers lctDN-for (59-GGAATTCCA-
TATGATTATTTCGTCCGCTAACG-39) and lctDN-rev (59-
CCGCTCGAGGCGTATATAAAATACGCCGTTTG-39)o r
lctDN-for and lctDC-rev (59- CTCGAGCTTACTTAAATCTA-
CTAATGC-39) to create the N-terminally or C-terminally his6-
tagged constructs respectively. Forward primers contained an
NdeI site and reverse primers contained an XhoI site. Products
were digested with NdeI and XhoI and ligated into the NdeI/
XhoI-digested pET15b expression vector (Novagen) for the his6 N-
terminal tag or the NdeI/XhoI-digested pET21a(+) expression
vector (Novagen) for the his6 C-terminal tag. The resultant
plasmids were transformed into E. coli DH5a and sequenced using
T7 promoter and SP6 terminator primers. Resulting plasmids
were named pSB201 (his6 N-terminal tag) and pSB203 (his6 C-
terminal tag). Plasmids were transformed into the expression strain
E. coli BL21(DE3) for expression and purification.
Protein Purification
E. coli BL21(DE3) carrying pSB201 or pSB203 were grown in TB
(EMD) containing 75 mg/ml ampicillin to an OD600 nm=0.6, and
induced overnight at 16uC with 100 mM IPTG in the presence of
100 mM riboflavin (Sigma). Induced cells were harvested by
centrifugation for 15 minutes at 61006g in a Beckman Coulter
Avanti J–E centrifuge at 4uC. The pellet was resuspended in 3 ml
Figure 6. Pyruvate is a poor inhibitor of LctD-his6. The ability of
pyruvate and oxalate to inhibit LctD-his6 enzymatic activity was
assessed as described in Materials and Methods. 50% inhibition of
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10 mMflavinadenine dinucleotide (FAD), pH 7.07)containingone-
half tablet complete Mini protease inhibitor cocktail (Roche), 25 U
Benzonase Nuclease (Novagen) and 10 mM FAD (Alfa Aesar). The
cells were passed three times through a French press (American
Instruments Company) at 20,000 pounds/square inch. The
resulting lysate was centrifuged at 60,0006g in a Beckman-Coulter
OptimaL 100 K Ultracentrifuge for one hour at 4uC to remove
cellular debris and insoluble protein. The lysate was then applied to
a HisTrap HP column (GE Healthcare). The column was washed
with 3 ml cold buffer B (25 mM phosphate buffer, 0.5 M NaCl,
10 mM FAD, pH 7.07) containing 0.15 M imidazole, followed by
elution with cold buffer B containing 0.5 M imidazole. The eluted
protein was concentrated, and a buffer exchange was performed
with 25 mM phosphate buffer containing 10 mM FAD. Samples
were separated on a 10% SDS-PAGE gel and stained with
Coomassie Brilliant Blue (Pierce). Bradford analysis to quantify
protein was performed with the Bio-Rad Protein Assay as outlined
by the manufacturer. Western blot analysis was performed as
outlined [26] using a commercially available anti-his6 antibody
(Sigma) and a stabilized goat anti-mouse HRP-conjugated second-
ary antibody (Pierce). Chemiluminescent detection was performed
using the SuperSignal West Dura Extended Duration Substrate as
outlined by the manufacturer (Thermo). Blots were imaged with a
G-box gel documentation system (Syngene). As a control, a
purification procedure was carried out as described above with
BL21(DE3) cells containing the parent plasmid pET21a(+).
Characterization of LctD-his6 Enzymatic Activity
Activity assays were performed with phenazine methosulfate
(PMS) (Acros Organics) and 3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyl-2H-tetrazolium bromide (MTT) (Calbiochem) as previ-
ously described [15,16,17]. To initially examine enzymatic activity
of LctD-his6, reactions (1.5 ml) were carried out in 0.08 M Tris
buffer containing 120 mg/ml PMS, 60 mg/ml MTT, 2 mM
substrate (L-lactate, D-lactate, or pyruvate), and 100 nM LctD-
his6. Reactions containing pyruvate as the substrate also contained
1 mM NADH. Half of the reaction volume was removed at time
zero, heated at 65uC for 5 minutes, chilled on ice, and stored at
280uC overnight. The remaining half of the reaction was
processed in the same manner at 15 minutes, and all samples
were filtered through a 0.2 mm Nanosep centrifugal device (Pall).
Product analysis was carried out on a Varian HPLC using a
Varian Metacarb 87H 30066.5 mm column at 35uC. Samples
were eluted with 0.025 N H2SO4 isocratic elution buffer with a
flow rate of 0.5 ml/minute. A Varian refractive index (RI) detector
at 35uC was used for product detection with commercially
available L-lactate, D-lactate, and pyruvate as standards.
For kinetic analysis, assays were performed monitoring a PMS-
coupled reduction of MTT as previously described [15,16,17]. The
assay was performed in 0.08 M Tris-HCl (pH 8.6) containing
60 mg/ml MTT, 240 mg/ml PMS, and a range of purified enzyme.
Absorbance changes in MTT were measured at 570 nm over 10
minutes. Absorbance values obtained from enzyme containing
reactions were adjusted by subtracting background absorbance
values from a reaction containing no enzyme. Calculations were
performed using an extinction coefficient of 17 mM
21 cm
21 [27].
For inhibition studies, the activity assays described above were
performed in the presence of increasing concentrations (0.05 to
50 mM) of pyruvate (Alfa Aesar) or oxalate (Fisher).
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